Key facts
- This page summarizes Mitchell Creem's Form 4 filing for Nutex Health, Inc. (NUTX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 08 Apr 2022, 14:42.
Mitchell Creem - 01 Apr 2022 Form 4 Insider Report for Nutex Health, Inc. (NUTX)
- Reporting relationship
- Director
- Issuer ticker
- NUTX
- Reported as of
- 01 Apr 2022
- Net transaction value
- +$500,500
- SEC form
- 4
- Accepted by SEC
- 08 Apr 2022, 14:42:25 UTC
- Next SEC filing
- 30 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- Mitchell Creem
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mitchell Creem filed Form 4 for Nutex Health, Inc. (NUTX) on 08 Apr 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$500,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NUTX
transaction
Derivative
Director Stock Option (right to buy)
Award
- Transaction value
- $500,500
- Shares
- +182,000
- Change %
- +140%
- Price
- $2.75*
- Shares after
- 312,120
- Date
- 01 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 182,000
- Exercise price
- $2.75
* marks a reported price that did not pass the local price check.